BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 12491202)

  • 1. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.
    Cosgrove SE; Sakoulas G; Perencevich EN; Schwaber MJ; Karchmer AW; Carmeli Y
    Clin Infect Dis; 2003 Jan; 36(1):53-9. PubMed ID: 12491202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Ayau P; Bardossy AC; Sánchez-Rosenberg GF; Ortiz R; Moreno D; Hartman P; Rizvi K; Prentiss TC; Perri MB; Mahan M; Huang V; Reyes K; Zervos MJ
    Int J Infect Dis; 2017 Aug; 61():3-6. PubMed ID: 28533166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant
    Liu T; Zhang Y; Wan Q
    Infect Drug Resist; 2018; 11():647-658. PubMed ID: 29765236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis: Females at Higher Risk of Death From Staph Infection.
    Anderer S
    JAMA; 2024 Apr; 331(14):1172. PubMed ID: 38488812
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential Time to Positivity as a Prognostic Indicator in
    Comba IY; Go JR; Vaillant J; O'Horo JC; Stevens RW; Palraj R; Abu Saleh O
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae173. PubMed ID: 38617074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
    Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus infections.
    Lowy FD
    N Engl J Med; 1998 Aug; 339(8):520-32. PubMed ID: 9709046
    [No Abstract]   [Full Text] [Related]  

  • 8. Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
    Klevens RM; Morrison MA; Nadle J; Petit S; Gershman K; Ray S; Harrison LH; Lynfield R; Dumyati G; Townes JM; Craig AS; Zell ER; Fosheim GE; McDougal LK; Carey RB; Fridkin SK;
    JAMA; 2007 Oct; 298(15):1763-71. PubMed ID: 17940231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection.
    Engemann JJ; Carmeli Y; Cosgrove SE; Fowler VG; Bronstein MZ; Trivette SL; Briggs JP; Sexton DJ; Kaye KS
    Clin Infect Dis; 2003 Mar; 36(5):592-8. PubMed ID: 12594640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in Staphylococcus aureus Bacteremia.
    van Hal SJ; Jensen SO; Vaska VL; Espedido BA; Paterson DL; Gosbell IB
    Clin Microbiol Rev; 2012 Apr; 25(2):362-86. PubMed ID: 22491776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies.
    Kaasch AJ; Barlow G; Edgeworth JD; Fowler VG; Hellmich M; Hopkins S; Kern WV; Llewelyn MJ; Rieg S; Rodriguez-Baño J; Scarborough M; Seifert H; Soriano A; Tilley R; Tőrők ME; Weiß V; Wilson AP; Thwaites GE;
    J Infect; 2014 Mar; 68(3):242-51. PubMed ID: 24247070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.
    Cosgrove SE
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S82-9. PubMed ID: 16355321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of antimicrobial resistance on health and economic outcomes.
    Cosgrove SE; Carmeli Y
    Clin Infect Dis; 2003 Jun; 36(11):1433-7. PubMed ID: 12766839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waves of resistance: Staphylococcus aureus in the antibiotic era.
    Chambers HF; Deleo FR
    Nat Rev Microbiol; 2009 Sep; 7(9):629-41. PubMed ID: 19680247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
    Hiramatsu K; Hanaki H; Ino T; Yabuta K; Oguri T; Tenover FC
    J Antimicrob Chemother; 1997 Jul; 40(1):135-6. PubMed ID: 9249217
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of nasal carriage in Staphylococcus aureus infections.
    Wertheim HF; Melles DC; Vos MC; van Leeuwen W; van Belkum A; Verbrugh HA; Nouwen JL
    Lancet Infect Dis; 2005 Dec; 5(12):751-62. PubMed ID: 16310147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of methicillin-resistant Staphylococcus aureus.
    Boucher HW; Corey GR
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S344-9. PubMed ID: 18462089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
    Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-associated meticillin-resistant Staphylococcus aureus.
    DeLeo FR; Otto M; Kreiswirth BN; Chambers HF
    Lancet; 2010 May; 375(9725):1557-68. PubMed ID: 20206987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.